New Equity Investment Aims to Develop New Duchenne Muscular Dystrophy Drug
source: pixabay.com

New Equity Investment Aims to Develop New Duchenne Muscular Dystrophy Drug

According to a story from CureDuchenne, the biotechnology company Dyne Therapeutics recently announced that CureDuchenne Ventures has made an equity investment that will support the development of all new precision…

Continue Reading New Equity Investment Aims to Develop New Duchenne Muscular Dystrophy Drug

“Stay at Home Right Now- Because My Kid Can’t” : A Mother Talks About COVID-19 and Her Immunosuppressed Daughter

Emily Knakmuhs's two-and-a-half-year-old Kennedie had just made it past a tough couple of years. When she was born, her family noticed she wasn't growing, but her pediatrician attributed it to…

Continue Reading “Stay at Home Right Now- Because My Kid Can’t” : A Mother Talks About COVID-19 and Her Immunosuppressed Daughter
CRISPR as a Tool to Treat Facioscapulohumeral Muscular Dystrophy
qimono / Pixabay

CRISPR as a Tool to Treat Facioscapulohumeral Muscular Dystrophy

  According to a press release from the Boston Children's Hospital, a study has discovered the efficacy of CRISPR-Cas9 gene-editing technology in the treatment of facioscapulohumeral muscular dystrophy (FSHD). As…

Continue Reading CRISPR as a Tool to Treat Facioscapulohumeral Muscular Dystrophy
Company Raises $80 Million to Develop Treatment for Cystic Fibrosis Linked to Rare Mutations
source: pixabay.com

Company Raises $80 Million to Develop Treatment for Cystic Fibrosis Linked to Rare Mutations

According to a story from Fierce Biotech, there have been some impressive advances in the treatment of cystic fibrosis recently. The latest milestone was in developing and approving the drug…

Continue Reading Company Raises $80 Million to Develop Treatment for Cystic Fibrosis Linked to Rare Mutations
Novartis Cosentyx® Receives Positive CHMP Opinion for Non-Radiographic Axial Spondyloarthritis Treatment
source: pixabay.com

Novartis Cosentyx® Receives Positive CHMP Opinion for Non-Radiographic Axial Spondyloarthritis Treatment

  According to a press release on Global Newswire, Novartis has received a positive opinion on Cosentyx® from the Committee for Medicinal Products for Human Use (CHMP). This positive opinion…

Continue Reading Novartis Cosentyx® Receives Positive CHMP Opinion for Non-Radiographic Axial Spondyloarthritis Treatment

Post Mortem Gene Therapy Suggests Hopeful Results for Parkinson’s Disease Treatment

  Research findings can sometimes come from unexpected places. For example, according to Parkinson's News Today, the benefits and shortcomings of an investigative gene therapy were explored through the post-mortem analysis…

Continue Reading Post Mortem Gene Therapy Suggests Hopeful Results for Parkinson’s Disease Treatment
Exclusive Distribution Agreement in Turkey for ONPATTRO to Treat Hereditary ATTR Amyloidosis
Sourced from: Nephron / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

Exclusive Distribution Agreement in Turkey for ONPATTRO to Treat Hereditary ATTR Amyloidosis

  According to a press release from FirstWord Pharma, Gen and Alnylam Pharmaceuticals have signed an exclusive distribution deal in Turkey for RNAi therapeutic ONPATTRO. This therapy drug will treat…

Continue Reading Exclusive Distribution Agreement in Turkey for ONPATTRO to Treat Hereditary ATTR Amyloidosis
Do We Really Know Our Health Situation? A Patient with Takayasu’s Arteritis Speaks Out
source: pixabay.com

Do We Really Know Our Health Situation? A Patient with Takayasu’s Arteritis Speaks Out

  "A steak saved my life," writes columnist Damon Young, 41, in his article for GQ, as he shares the story of his diagnosis with Takayasu's arteritis. After over-indulging at dinner,…

Continue Reading Do We Really Know Our Health Situation? A Patient with Takayasu’s Arteritis Speaks Out
Questions for COVID-19: Should Cancer Patients Attend Appointments?
Photo by National Cancer Institute on Unsplash

Questions for COVID-19: Should Cancer Patients Attend Appointments?

  In a period of unprecedented changes, it is understandable that people may question what their lives may look like moving forward. COVID-19 has now spread to 196 countries and…

Continue Reading Questions for COVID-19: Should Cancer Patients Attend Appointments?
Newborn Screening Tests Help Catch Fabry Disease Before Irreversible Symptoms Begin
source: pixabay.com

Newborn Screening Tests Help Catch Fabry Disease Before Irreversible Symptoms Begin

As originally reported in Fabry Disease News, the potentially fatal genetic disorder Fabry disease can be diagnosed most effectively in infancy by newborn screening programs. By identifying the disease early,…

Continue Reading Newborn Screening Tests Help Catch Fabry Disease Before Irreversible Symptoms Begin

This Journal Highlights Current Research on Neuromuscular Diseases (NMD)

In a Special Issue of the journal Disease Models and Mechanisms Highlights, James J. Dowling et al describes pediatric neuromuscular diseases as mostly genetic and affecting areas of the peripheral…

Continue Reading This Journal Highlights Current Research on Neuromuscular Diseases (NMD)
Two Part Treatment Proven Superior for Pulmonary Arterial Hypertension
source: pixabay.com

Two Part Treatment Proven Superior for Pulmonary Arterial Hypertension

According to a story from Pulmonary Hypertension News, the results of a recent phase 3 clinical trial have determined that patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) stand…

Continue Reading Two Part Treatment Proven Superior for Pulmonary Arterial Hypertension